Stay updated on Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    4%
    Check dated 2025-06-19T19:41:56.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T11:16:58.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T06:01:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T14:17:45.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T10:17:36.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T05:13:50.000Z thumbnail image

Stay in the know with updates to Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.